BFSG »

Lenz Therapeutics shares owned by BFSG

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by BFSG from 13F filings

Historical chart of BFSG investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by BFSG consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by BFSG

Quarter filed Position value Share count Share price at filing
2025-09-30 $30k 635 46.58

More positions owned by BFSG

Vanguard Index Fds Total Stk Mkt (VTI)
Nvidia Corporation Put Put Option (Principal) (NVDA)
Microsoft Corporation (MSFT)
Ishares Gold Tr Ishares New (IAU)
Ishares Tr Core S&p500 Etf (IVV)
Newmont Mining Corporation (NEM)
Apple (AAPL)
Etfs Gold Tr Physcl Gold Shs (SGOL)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Raytheon Technologies Corp (RTX)
Spdr Gold Tr Gold Shs (GLD)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Alphabet Cap Stk Cl C (GOOG)
Marvell Technology (MRVL)

View all positions for BFSG

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
Vanguard Group
UBS Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Morgan Stanley
Geode Capital Management

View all funds holding Lenz Therapeutics